Assertio Therapeutics, Inc Business Finance Contracts & Agreements
48 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Exchange Agreements (1)
- Indenture Agreements (4)
- Loan Agreements (1)
- Note Agreements (7)
- Purchase Agreements (10)
- Release Agreements (6)
- Repurchase Agreements (1)
- Security Agreements (1)
- Stock Agreements (13)
- Underwriting Agreements (2)
- Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 20, 2020)
- Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 7, 2020)
- Asset Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics Inc., Golf Acquiror LLC and, solely for the purposes set forth therein, Celtic Intermediate... (Filed With SEC on December 12, 2019)
- Sixth Amendment to Note Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics, Inc., certain subsidiaries of Assertio Therapeutics, Inc. party thereto,... (Filed With SEC on December 12, 2019)
- Third Supplemental Indenture, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New York Mellon Trust Company, N.A. as Trustee (Filed With SEC on November 7, 2019)
- Form of Third Supplemental Indenture, expected to be dated on or around August 13, 2019, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New... (Filed With SEC on August 9, 2019)
- Fifth Amendment to Note Purchase Agreement, dated August 9, 2019 (Filed With SEC on August 9, 2019)
- Form of Exchange Agreement (Filed With SEC on August 9, 2019)
- Fourth Amendment to Note Purchase Agreement, dated January 8, 2019 (Filed With SEC on January 9, 2019)
- Amended and Restated 2004 Employee Stock Purchase Plan (Filed With SEC on November 9, 2018)
- Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale, dated August 2, 2018, by and among Depomed, Inc., Depo DR Sub, LLC, and PDL Investment Holdings, LLC (as... (Filed With SEC on August 8, 2018)
- Waiver, Consent and Third Amendment to Note Purchase Agreement and Partial Release of Security Interest, dated August 2, 2018 (Filed With SEC on August 2, 2018)
- Waiver and Second Amendment to Note Purchase Agreement, dated as of December 4, 2017 (Filed With SEC on December 14, 2017)
- Waiver and Release Agreement dated July 12, 2017 by and between the Company and Thadd M. Vargas (Filed With SEC on November 9, 2017)
- DEPOMED, INC. Waiver and Release Agreement (Filed With SEC on August 7, 2017)
- DEPOMED, INC. WAIVER AND RELEASE AGREEMENT (Filed With SEC on May 10, 2017)
- CONSENT AND FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT (Filed With SEC on February 26, 2016)
- ASSIGNMENT AND CONSENT AGREEMENT (Filed With SEC on May 11, 2015)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on May 11, 2015)
- NOTE PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- ASSET PURCHASE AGREEMENT between Janssen Pharmaceuticals, Inc. and Depomed, Inc. DATED AS OF JANUARY 15, 2015 (Filed With SEC on February 26, 2015)
- DEPOMED, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A, as Trustee First Supplemental Indenture Dated as of September 9, 2014 to Indenture Dated as of September 9, 2014... (Filed With SEC on September 9, 2014)
- DEPOMED, INC. Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. Trustee INDENTURE Dated as of September 9, 2014 Senior Debt Securities (Filed With SEC on September 9, 2014)
- DEPOMED, INC. 2.50% CONVERTIBLE SENIOR NOTES DUE 2021 UNDERWRITING AGREEMENT (Filed With SEC on September 9, 2014)
- ASSET PURCHASE AGREEMENT by and between NAUTILUS NEUROSCIENCES, INC., as Seller and DEPOMED, INC., as Purchaser Dated as of December 17, 2013 (Filed With SEC on March 17, 2014)
- ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser (Filed With SEC on March 17, 2014)
- DEPOMED, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As Amended February 19, 2014 (Filed With SEC on March 17, 2014)
- ASSET PURCHASE AGREEMENT by and among ARCHIMEDES PHARMA US INC., ARCHIMEDES PHARMA LTD., ARCHIMEDES DEVELOPMENT LTD. and DEPOMED, INC. July 29, 2013 (Filed With SEC on November 7, 2013)
- DEPOMED, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As Amended May 15, 2012 (Filed With SEC on August 3, 2012)
- ASSET PURCHASE AGREEMENT by and between DEPOMED, INC. and XANODYNE PHARMACEUTICALS, INC. Dated as of June 21, 2012 (Filed With SEC on August 3, 2012)
- AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 8, 2008)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 8, 2008)
- TERMINATIONAND ASSIGNMENT AGREEMENT (Filed With SEC on March 12, 2008)
- 2004 EMPLOYEE STOCK PURCHASE PLAN OF DEPOMED, INC (Filed With SEC on August 8, 2007)
- COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on April 23, 2007)
- DEPOMED, INC. 1995 STOCK OPTIONPLAN NOTICE OF EXERCISE (Filed With SEC on March 16, 2007)
- DEPOMED, INC. 1995 STOCK OPTION PLAN NONSTATUTORY STOCK OPTIONAGREEMENT (Filed With SEC on March 16, 2007)
- AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2007)
- COMMON STOCK PURCHASE AGREEMENT Dated December 11, 2006 by and between DEPOMED, INC. and AZIMUTH OPPORTUNITY LTD. (Filed With SEC on December 12, 2006)
- MANUFACTURINGTRANSFER AGREEMENT (Controlled Release Metformin Formulations USA) (Filed With SEC on March 16, 2006)
